Jane Anau
Kaiser Permanente
27 Papers
79 Citations
Jane Anau is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Medicine & Type 2 diabetes. The author has an hindex of 12, co-authored 21 publications. Previous affiliations of Jane Anau include Group Health Research Institute & Group Health Cooperative.
Chat about Author
Papers
Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
David Fisher,Eric O. Johnson,Sebastien Haneuse,David Arterburn,Karen J. Coleman,Patrick J. O'Connor,Rebecca O'Brien,Andy Bogart,Mary Kay Theis,Jane Anau,Emily B. Schroeder,Stephen Sidney +11 more
TL;DR: In this retrospective, matched cohort study of patients with type 2 diabetes and severe obesity who underwent surgery, compared with those who did not undergo surgery, bariatric surgery was associated with a lower risk of macrovascular outcomes.
Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study.
David Arterburn,Robert J. Wellman,Ana Emiliano,Steven R. Smith,Andrew O. Odegaard,Sameer B. Murali,Neely Williams,Karen J. Coleman,Anita P. Courcoulas,R. Yates Coley,Jane Anau,Roy Pardee,Sengwee Toh,Cheri Janning,Andrea J. Cook,Jessica L. Sturtevant,Casie Horgan,Kathleen M. McTigue,PCORnet Bariatric Study Collaborative +18 more
TL;DR: Findings on the comparative effectiveness of SG, RYGB, and AGB for weight loss among adults at 1, 3, and 5 years after surgery are presented.
250
Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.
Kathleen M. McTigue,Robert J. Wellman,Elizabeth Nauman,Jane Anau,R. Yates Coley,Alberto M Odor,Julie Tice,Karen J. Coleman,Anita P. Courcoulas,Roy Pardee,Sengwee Toh,Cheri Janning,Neely Williams,Andrea Cook,Jessica L. Sturtevant,Casie Horgan,David Arterburn,Corrigan L. McBride,James C. McClay,Jeanne M. Clark,Thomas H. Inge,Michelle R. Lent,David G. Schlundt,Meredith C. Duke,Steven R. Smith,Andrew O. Odegaard,Nirav K. Desai,Ali Tavakkoli,Elizabeth Cirelli,Stavra A. Xanthakos,Laura J. Rasmussen-Torvik,Marc P. Michalsky,Matthew F. Daley,Gabrielle Purcell,Sameer B. Murali,Ana Emiliano,Rhonda G. Kost,Caroline M. Apovian,Donald T. Hess,Cynthia A. Blalock,Elisha Malanga,Jay Desai,Joe Nadglowski,John H. Holmes,Joseph Vitello,Michael A. Horberg,Robert T. Greenlee,Stephanie L. Fitzpatrick,Roni Zeiger,Molly B. Conroy,Douglas S. Bell,Jamy D. Ard,Jing Bian,Bipan Chan,Michael A. Edwards,Christina C. Wee,Daniel B. Jones,Jennifer L. Kraschnewski,Kirk W. Reichard,Howard S. Gordon,David O. Meltzer,Erin D. Roe,William Richardson,Sameer Malhotra,Lindsay G. Cowell,Lydia A. Bazzano,Jefferey S. Brown,Andrea J. Cook +67 more
TL;DR: Patients who had Roux-en-Y gastric bypass showed slightly higher T2 DM remission rates, better glycemic control, and fewer T2DM relapse events than patients who had sleeve gastrectomy.
Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.
Rebecca O'Brien,Eric O. Johnson,Sebastien Haneuse,Karen J. Coleman,Patrick J. O'Connor,David Fisher,Stephen Sidney,Andy Bogart,Mary Kay Theis,Jane Anau,Emily B. Schroeder,David Arterburn +11 more
TL;DR: In this paper, the authors investigated the relationship between bariatric surgery and incident microvascular complications of type 2 diabetes mellitus (T2DM) and found that bariatric procedures (76% gastric bypass, 17% sleeve gastrectomy, and 7% adjustable gastric banding) compared with usual care.
Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery.
Karen J. Coleman,Sebastien Haneuse,Eric Johnson,Andy Bogart,David Fisher,Patrick J. O'Connor,Nancy E. Sherwood,Steve Sidney,Mary Kay Theis,Jane Anau,Emily B. Schroeder,Rebecca O'Brien,David Arterburn +12 more
TL;DR: Support is provided for a legacy effect of bariatric surgery, where even a transient period of surgically induced type 2 diabetes remission is associated with lower long-term microvascular disease risk.
100